Biotechnology Expert Group

biotechnology
Lisa-Zannoni.PNG

Chair

Lisa Zannoni

Zannoni & Associates Consulting (USA)
Dominik-Kummerle

Lead

Dominik Kümmerle

Policy Director

Vice-Chair

Dirk Carrez

Clever Consult (Belgium)

Vice-Chair

Alessandra Salamini

Bayer (USA)

  • 01.

    Overview

    Our Biotechnology Expert Group provides private sector access to the wide range of OECD biotechnology–related projects, including industrial biotechnology, human health–related biotechnology, the harmonization of regulatory oversight for the products of modern biotechnology, and international harmonization in the safety assessments of novel foods and feeds. Through the Biotechnology Expert Group, business contributes to both technical and strategic discussions on the various applications of biotechnology. A major focus for the coming years will be on how biotechnology can contribute to addressing global challenges including health and green growth.

  • 03.

    Business engagement at OECD

    The OECD serves its members as a forum on the regulation of modern biotechnology, including novel foods and feeds. As part of its Chemicals program, the Organization fosters a mutual understanding of regulations, facilitates harmonization of risk/safety assessments, and promotes the safe use of modern biotechnology products. Further, the OECD analyzes policies to encourage innovation in biotechnology – including by addressing policy issues related to biotechnology, nanotechnology and their convergence with other technologies (e.g. information and communications technologies (ICTs).
     
    Our Biotechnology Expert Group contributes to the work of the following OECD bodies:
    • OECD Chemicals and Biotechnology Committee
    • OECD Working Party on the Harmonization of Regulatory Oversight in Biotechnology
    • OECD Working Party on the Safety of Novel Foods and Feeds
    • OECD Working Party on Biotechnology, Nanotechnology and Converging Technologies
  • 02.

    2022 priorities

    • Harmonization of regulatory oversight
    • Increasing efficiency of safety assessment
    • Safety of novel foods and feeds
    • Industrial biotechnology, bio–based production, innovation for sustainable bio–economies
    • Emerging technologies for health: microbiome, gene–editing, neurotechnology, precision medicine